hpv vaccine

Boys should get HPV vaccine too, panel says

Headlines from the Associated Press  Tue, 10/25/2011 - 10:40

ATLANTA (AP) -- A government panel wants young boys as well as girls to get the controversial HPV vaccine, in part to prevent them from spreading the sexually transmitted virus to girls....


 

HPV Vaccine: Early Evidence of Impact

WebMD Health  Fri, 06/17/2011 - 10:33

Group of young women

An early report suggests that the HPV vaccine is preventing the abnormal lesions that lead to cervical cancer.


 

HPV vaccine works for boys: Study shows first clear benefits

EurekAlert! - Infectious and Emerging Diseases  Thu, 02/03/2011 - 23:00

(University of California - San Francisco) A 4,000-patient clinical trial that spanned 18 countries has shown the first published data that the HPV vaccine works in young men and boys.


 

Adult HPV Vaccines: Schedule, Side Effects, Who Should Get the V...

WebMD Health  Fri, 01/21/2011 - 09:52

adult vaccine injection

WebMD explains what the HPV vaccine is, who needs to get it, and possible side effects.


 

Doctors not strongly encouraging HPV vaccine to girls of certain...

EurekAlert! - Medicine and Health  Sun, 08/01/2010 - 22:00

(University of Colorado Denver) Doctors are not strongly encouraging girls ages 11-12 to get the HPV vaccine, despite guidelines.


 

IAC: HPV Vaccine Effective in Men (CME/CE)

MedPage Today Infectious Disease  Fri, 07/23/2010 - 08:00

VIENNA (MedPage Today) -- A quadrivalent vaccine against four strains of human papillomavirus was highly effective at reducing external genital lesions in men, a researcher said here.


 

SGO: HPV Vaccine Stops Recurrence After Surgery (CME/CE)

MedPage Today Infectious Disease  Fri, 03/19/2010 - 09:29

SAN FRANCISCO (MedPage Today) -- Vaccination against human papillomavirus (HPV) significantly reduced the risk of recurrence after surgery for HPV-related cervical lesions, according to data reported here.


 

FDA Panel Votes to Approve Second HPV Vaccine

MedPage Today Infectious Disease  Wed, 09/09/2009 - 16:08

WASHINGTON — An FDA advisory panel today voted to recommend approval of GlaxoSmithKline’s Cervarix vaccine for use against the two strains of human papillomavirus (HPV) that cause 70% of cervical cancers.